The Experiences of People Living with HIV/AIDS, On Antiretroviral Medications
This study has been conducted specifically
to explore the experiences of people living with HIV/AIDS and taking
antiretroviral medications in Nairobi. This study specifically sought to:
describe individuals’ feelings before and after initiation of antiretroviral
medications; ascertain whether there is stigma associated with taking
antiretroviral medications; Identify support mechanisms available for people
taking antiretroviral medications; describe challenges individuals face as a
result of taking antiretroviral medications, and establish coping mechanisms
available for antiretroviral medication related challenges.
This study was a cross sectional
qualitative inquiry that used in-depth interviews to explore the experiences of
people on antiretroviral medications in Nairobi. The results showed that before
taking antiretroviral medications, participants were feeling hopeless, sad and
frustrated. However, when they started the antiretroviral medications, their
feelings changed positively to feelings of hope and courage. Family support is crucial
for good adherence to antiretroviral medications; though these medications pose
the greatest challenge of treatment side effects. In summary, this study showed
that antiretroviral medications are a greatest investment in the physical,
medical and psychosocial welfare for people living with HIV/AIDS.
[1.] Chantler. (2005). From disconnection to connection:
Race, gender and the politics of therapy. British
Journal of Guidance & Counselling, 33(2), pp. 239-256.
[2.] Dlamini, P.S., Wantland, D., Makoae, L.N., Chirwa, M.,
Kohi, T.W., Greeff, M., … Holzemer, W. L. (2009). HIV-stigma and missed
medications in HIV-positive people in five African countries. AIDS Patient Care STDS, 23(5), pp.
377_387. and psychological adjustment to HIV/AIDS. Psychosomatics, 44(6),
[3.] Gilbert, L., & Walker, L. (2009). Stigma as
experienced by patients in an HIV/AIDS Clinic in Johannesburg, South Africa. Health & Social Care in the Community,
[4.] Kaai, S., Avina, S., Luchters, S., Geibel, S., Munyao,
P., Mandaliya, K., Shikely, K., Temmerman, M., and Rutenberg, N. (2007). Changes in stigma among a cohort of people
on antiretroviral therapy: Findings from Mombasa, Kenya. Nairobi:
Population Council HIV antiretroviral treatments,
access and adherence in an ethnically diverse sample of men who have sex with
men. AIDS Care, 15, pp. 89-102.
[5.] Logie, C., & Gadalla, T.M. (2009). Meta-analysis of health and demographic correlates of stigma
towards people living with HIV. AIDS
Care, 21(6), pp.742-753.
[6.] Pearson, C.R., Micek, M.A., Pfeiffer, J., Montoya, P., Matediane,
E., Jonasse, T., Gloyd, S. (2009). One year after ART initiation: Psychosocial
factors associated with stigma among HIV-positive Mozambicans. AIDS and Behaviour, 13(6), pp.1189-1196.
[7.] Rogers, C. (1951). Client-Centred
Therapy.: Constable: London
[8.] Simbayi, L.C., Kalichman, S., Strebel, A., Cloete, A.,
Henda, N., & Nqeketo, A. (2007). Internalized stigma, discrimination, and
depression among men and women living with HIV/AIDS in Cape Town, South Africa.
Social Science & Medicine, 64(9),
[9.] Smith, R., Rossetto, K., & Peterson, B.L. (2008). A
meta-analysis of disclosure of one’s HIV-positive status, stigma and social
support. AIDS Care, 20(10),
[10.] UNAIDS. (2009). Annual
Report, 2009: UNAIDS. Geneva:
[11.] Wolfe et al. (2008). The impact of universal access to antiretroviral therapy on HIV stigma
in Botswana. American journal of
Public Health 98(10), pp. 1865-1871.
[12.] Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R.,
O’Shaughnessy, M. V., & Montaner, J. S. (2003). Effect of medication
adherence on survival of HIV-infected adults who start highly active
antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 × 10(9) cells/L. Annals of Internal Medicine, 139,